Publications dans lesquelles il/elle collabore avec Cristina Sánchez González (20)

2023

  1. Elucidating the Therapeutic Potential of Bis(Maltolato)OxoVanadium(IV): The Protective Role of Copper in Cellular Metabolism

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

2022

  1. Effect of Bis(maltolato)oxovanadium(IV) on Zinc, Copper, and Manganese Homeostasis and DMT1 mRNA Expression in Streptozotocin-Induced Hyperglycemic Rats

    Biology, Vol. 11, Núm. 6

2021

  1. Ultra-small iron nanoparticles target mitochondria inducing autophagy, acting on mitochondrial dna and reducing respiration

    Pharmaceutics, Vol. 13, Núm. 1, pp. 1-18

  2. Vanadium decreases hepcidin mrna gene expression in stz-induced diabetic rats, improving the anemic state

    Nutrients, Vol. 13, Núm. 4

2020

  1. In vitro and in situ experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements

    Nanotoxicology, Vol. 14, Núm. 3, pp. 388-403

  2. In vitro study of the protective effect of manganese against vanadium-mediated nuclear and mitochondrial DNA damage

    Food and Chemical Toxicology, Vol. 135

2019

  1. Complementary techniques (spICP-MS, TEM, and HPLC-ICP-MS) reveal the degradation of 40 nm citrate-stabilized Au nanoparticles in rat liver after intraperitoneal injection

    Journal of Trace Elements in Medicine and Biology, Vol. 55, pp. 1-5

2018

  1. Gold nanoparticles: Distribution, bioaccumulation and toxicity. In vitro and in vivo studies

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 14, Núm. 1, pp. 1-12

  2. Quantitative assessment of the metabolic products of iron oxide nanoparticles to be used as iron supplements in cell cultures

    Analytica Chimica Acta, Vol. 1039, pp. 24-30

2017

  1. Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic rats

    Metallomics, Vol. 9, Núm. 3, pp. 258-267

  2. Speciation of gold nanoparticles and low-molecular gold species in Wistar rat tissues by HPLC coupled to ICP-MS

    Journal of Analytical Atomic Spectrometry, Vol. 32, Núm. 1, pp. 193-199

2014

  1. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent

    The Scientific World Journal, Vol. 2014

  2. Evaluation of the biological effect of Ti generated debris from metal implants: Ions and nanoparticles

    Metallomics, Vol. 6, Núm. 9, pp. 1702-1708

  3. Exposure to bis(maltolato)oxovanadium(IV) increases levels of hepcidin mRNA and impairs the homeostasis of iron but not that of manganese

    Food and Chemical Toxicology, Vol. 73, pp. 113-118

2013

  1. Aggravation by vanadium of magnesium deficiency in STZ-induced diabetic rats

    Magnesium Research, Vol. 26, Núm. 2, pp. 74-82

2012

  1. Absorption, transport and insulin-mimetic properties of bis(maltolato)oxovanadium (IV) in streptozotocin-induced hyperglycemic rats by integrated mass spectrometric techniques

    Analytical and Bioanalytical Chemistry, Vol. 402, Núm. 1, pp. 277-285

  2. Changes in the antioxidant defence and in selenium concentration in tissues of vanadium exposed rats

    Metallomics, Vol. 4, Núm. 8, pp. 814-819

  3. Effect of bis(maltolato)oxovanadium (IV) (BMOV) on selenium nutritional status in diabetic streptozotocin rats

    British Journal of Nutrition, Vol. 108, Núm. 5, pp. 893-899

2011

  1. Bioavailability, tissue distribution and hypoglycaemic effect of vanadium in magnesium-deficient rats

    Magnesium Research, Vol. 24, Núm. 4, pp. 196-208

2009

  1. Biospeciation of various antidiabetic VIVO compounds in serum

    Dalton Transactions, pp. 2428-2437